Warburg Research set a €56.00 ($66.67) price objective on Compugroup Medical (ETR:COP) in a research report report published on Thursday morning. The firm currently has a buy rating on the stock.

Several other analysts also recently weighed in on COP. Baader Bank set a €52.00 ($61.90) target price on Compugroup Medical and gave the stock a neutral rating in a research report on Wednesday. set a €61.00 ($72.62) target price on Compugroup Medical and gave the stock a buy rating in a research report on Wednesday, October 18th. Commerzbank set a €62.00 ($73.81) target price on Compugroup Medical and gave the stock a buy rating in a research report on Thursday. Berenberg Bank set a €53.00 ($63.10) target price on Compugroup Medical and gave the stock a neutral rating in a research report on Tuesday, September 19th. Finally, Deutsche Bank set a €60.00 ($71.43) target price on Compugroup Medical and gave the stock a buy rating in a research report on Monday, October 16th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus price target of €58.17 ($69.25).

Compugroup Medical (ETR COP) traded down €0.03 ($0.04) during trading hours on Thursday, hitting €55.72 ($66.33). The stock had a trading volume of 57,156 shares, compared to its average volume of 73,579. Compugroup Medical has a fifty-two week low of €36.12 ($43.00) and a fifty-two week high of €57.70 ($68.69).

ILLEGAL ACTIVITY NOTICE: “Compugroup Medical (COP) Given a €56.00 Price Target at Warburg Research” was first posted by Watch List News and is the property of of Watch List News. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.watchlistnews.com/compugroup-medical-cop-given-a-56-00-price-target-at-warburg-research/1766382.html.

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.